Fundraising FoxSanderling Ventures
Venture capitalSan Mateo · Seed–Late Stage · 7 people tracked
Also known as SANDERLING MANAGEMENT COMPANY, LLC
Find your way into Sanderling Ventures
Each arrow is one introduction. Sign up to fill in the first one.
Ask Mike Scott to introduce you to Fred Middleton
You →Mike · together at ViaCyte →Fred
Ask Jamie Chen to introduce you to Peter McWilliams
You →Jamie · together at Glycomine →Peter
Ask Sam Okafor to introduce you to Timothy Mills
You →Sam · together at Torax Medical →Timothy
- Michael Dixon4 people can intro you
- Pierre Beauparlant4 people can intro you
- Benjamin F. McGraw III4 people can intro you
Sign up to find every way you can get introduced to Sanderling Ventures
- Your email: who you already know at Sanderling Ventures, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Sanderling Ventures team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
Sanderling invests in and helps build biomedical companies, combining a specialized investment focus with active management and a long-term commitment. The firm emphasizes close working partnerships with entrepreneurs to build significant companies and generate strong returns for both founders and investors. Areas of specialization include small molecule therapeutics, biologics and vaccines, drug delivery, platform technologies, and medical devices.
Source: firm website, verified Sep 29, 2026.
Team · 7 people
from the firm's website
What they invest in
from 38 of 61 portfolio companiesHealthtech ×28Biotech ×25Medical Devices ×20Hardware ×4Digital Health ×3Deep Tech ×2Advanced Manufacturing ×1AI & Machine Learning ×1
HQs:United States×23Belgium×1Germany×1France×1Netherlands×1
Investments · 61 tracked
founders shown can be your intro pathBy year:2023 · 12020 · 22019 · 22017 · 22016 · 22015 · 12012 · 212 dated
HCW Biologics is a clinical-stage biopharmaceutical company developing fusion immunotherapeutics as first-in-class immunotherapies for autoimmune diseases, cancer, and senescence-associated dysplasia.
BiotechHealthtechLongevityMiramar, US
Hing C. Wong(Executive Officer, Director)Hing W.(Founder)inLee Flowers(Executive Officer)Rebecca Byam(Executive Officer)inPeter Rhode(Executive Officer)inPeter Sun(Director)
Board seatFred Middleton· per SEC Form D · $16M raise · filed Oct 2020
Co-investorsDeepWork Capital
Boston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
HealthtechMedical Devices
John AbeleinPeter NicholasLance BatesinJonathan R. Monson(Executive Vice President and Chief Financial Officer)Miriam O'Sullivan(Senior Vice President, Chief Human Resources Officer)inMichael F. Mahoney(Chairman of the Board, President and Chief Executive Officer)
Co-investorsAndera PartnersCatalyst Health VenturesCouncilExcelestar VenturesGood Growth CapitalKleiner Perkins+8 more
CalciMedica is a clinical-stage biopharmaceutical company developing CRAC (calcium release-activated calcium) channel inhibition therapies for serious acute and chronic inflammatory, immunologic, and cardiopulmonary diseases.
BiotechHealthtechLa Jolla, US
Kenneth A. Stauderman(Co-founder)inGonul Velicelebi(Co-founder)Daniel Geffken(Executive Officer)A. Rachel Leheny(Executive Officer, Director)Michael J. Dunn(Executive Officer)inStephen Bardin(Chief Financial Officer)in
Co-investorsAisling CapitalMESA VERDE VENTURE PARTNERSRevelation PartnersClarus LifesciencesClarus VenturesOrbiMed
Stereotaxis develops robotic systems for interventional medicine, focused on endovascular and cardiac procedures such as cardiac ablation.
HealthtechMedical DevicesRoboticsSaint Louis, US
Kimberly R. Peery(Executive Officer, Director)Paul A. Brathwaite(Vice President, Research and Development.)inMartin C Stammer(Chief Financial Officer.)David A Giffin(Vice President, Human Resources.)inFrank J. Cheng(Senior Vice President, Marketing and Business Development.)inDavid Fischel(Chairman & CEO)in
Co-investorsSupernova Invest
Artielle Immunotherapeutics develops DRhQ, a therapeutic platform that targets the CD74 receptor and inhibits macrophage migration inhibitory factor (MIF) to treat neuroinflammatory conditions such as progressive multiple sclerosis and advanced cancers.
BiotechDeep TechHealthtechPortland, US
Renee Shirley(Founder)
Co-investorsAvalon BioVenturesLifeX Ventures
BiotechMiramar, US
Hing C Wong(Executive Officer, Director)Peter Rhode(Executive Officer)
BoardAdam Waldman(Director)Fred Middleton(Director)C. Boyder Gray(Director)
Co-investorsNew World AngelsOberland Capital
Asteres builds ScriptCenter automated kiosks and lockers that let patients pick up pharmacist-filled prescriptions and healthcare products securely at any hour, while pharmacy staff retain control over filling and checking.
Digital HealthHardwareHealthtechMedical DevicesSan Diego, US
Linda Pinney(Founder)inPatrick Molino(Executive Officer)inMartin Bridges(Executive Officer)David J. Lenny(President & CEO)in
BoardTimothy J. Wollaeger(Executive Officer, Director)Robert G. McNeil(Director)
Philips provides cardiac monitoring and diagnostic solutions that connect patient monitoring across hospital and home settings.
Digital HealthHealthtechMedical Devices
Chimerix is a biopharmaceutical company developing therapies for rare diseases and cancers, with a focus on advancing treatments through biomarker-driven approaches and precision medicine.
BiotechHealthtechMedical DevicesDurham, US
Mike Sherman(Chief Executive Officer and President)W. Garrett Nichols(Chief Medical Officer)Michael A. Alrutz(Executive Officer)Randall Lanier(Chief Science Officer)Roy W. Ware(Chief Manufacturing and Technology Officer)Heather Knight-Trent(Vice President of Regulatory Affairs)
Co-investorsAisling CapitalAlta PartnersAsset Management CompanyCanaan PartnersFrazier Life SciencesPappas Capital
DalCor Pharmaceuticals is a biopharmaceutical company developing dalcetrapib, a pharmacogenetic precision medicine for cardiovascular disease that targets patients with the ADCY9 AA genotype.
BiotechDeep TechDigital Health
Fouzia Laghrissi-Thode(Chief Executive Officer)inMichael Dixon(Chief Financial Officer)inTherese Heinonen(Chief Development Officer)inDiane Sullivan(Chief Commercial Officer)
Dendreon develops and manufactures cellular immunotherapies, including PROVENGE (sipuleucel-T), an FDA-approved cellular immunotherapy for prostate cancer patients.
BiotechHealthtech
William Amickin
Co-investorsRho Capital PartnersRho Ventures
Skyepharma is a contract development and manufacturing organization (CDMO) specializing in classic and complex oral solid dosage forms, offering product development, manufacturing, and packaging services.
Advanced ManufacturingBiotechHealthtechMedical DevicesFrance, FR
Sébastien Mas(CEO)inNicolas Bedel(Chief Business Officer)inLudivine Laugerette(Quality Director & Qualified Person Site)inChahrazed Derbal(Manufacturing Director)inVirginie Mattens(Head of Human Resources)in
DePuy Synthes develops orthopedic medical devices and solutions including joint reconstruction, trauma, extremities, craniomaxillofacial, spinal surgery, and sports medicine products, along with digital surgery technologies.
HealthtechMedical Devices
Digirad manufactures portable nuclear medicine imaging cameras for cardiology and general nuclear imaging applications.
HardwareMedical DevicesSuwanee, US
Matthew G. Molchan(Executive Officer, Director)David Noble(Executive Officer)John W. Sayward(Director)Michael A. Cunnion(Director)Dimitrios J. Angelis(Director)John M. Climaco(Director)
Dynavax is a commercial-stage biopharmaceutical company that develops and commercializes vaccines against infectious diseases using its adjuvant technology.
BiotechHealthtechDüsseldorf, DE
Ryan Spencer(Chief Executive Officer)inDavid Novack(President and Chief Operating Officer)inRobert Janssen(Chief Medical Officer and Senior Vice President, Clinical Development)inKelly MacDonald(Chief Financial Officer)inJeff Coon(Chief Human Resources Officer)Donn Casale(Chief Commercial Officer)in
Co-investorsBain Capital Life SciencesHealthCap
Ethicon develops surgical products and technologies including wound closure, hemostats, surgical stapling, surgical energy, antimicrobial dressings, and surgical instruments, along with clinical education programs for surgeons.
HealthtechMedical Devices
Co-investorsCalifornia Technology Ventures
Glycomine develops therapeutics for rare diseases, many of which currently lack disease-modifying treatment options.
BiotechSan Francisco, US
Agnes Rafalko(Executive Officer, Director)inSteven Axon(Chief Executive Officer)inHicham Alaoui(Chief Scientific Officer)inRose Marino(Chief Medical Officer)inPeter McWilliams(Chief Business Officer)Geoffrey Hird(Chief Technology Officer)in
Co-investorsAdvent Life SciencesAsahi Kasei Corporate Venture CapitalChiesi VenturesCTI Life Sciences Fund L.P.Mission Bay CapitalMission Biocapital+6 more
Immunotherapy oncology company engineering technologies to activate the immune system; acquired by Merck in February 2019 for $0.3B.
BiotechHealthtechMedical DevicesSeattle, US
David Baltimore(Director)Carlos V. Paya(Executive Officer, Director)Stephen R. Brady(Executive Officer)inJan Henrik ter Meulen(Executive Officer)Paul Rickey(Executive Officer)inWayne Gombotz(Executive Officer)in
Co-investorsAisling CapitalAtlas VentureHM Venture PartnersOUP (Osage University Partners)Sanofi VenturesSPRINGROCK VENTURES+4 more
Philips develops health technology and consumer products for patients, healthcare providers, and households, with an emphasis on durable, recyclable products.
Circular EconomyConsumerHealthtechMedical DevicesAmsterdam, NL
Co-investorsExcel Venture ManagementNew Enterprise Associates (NEA)H.I.G. BioHealth PartnersH.I.G. Capital
InterMune was a Brisbane, California biotechnology company focused on pulmonology and fibrotic diseases, best known for developing pirfenidone (Esbriet) to treat idiopathic pulmonary fibrosis.
daniel welchin
Co-investorsRidgeback CapitalSofinnova Ventures
Bionano Genomics develops optical genome mapping (OGM) systems, software, and sample-preparation tools for detecting structural variants and chromosomal aberrations across cancer, genetic disease, reproductive health, and cell therapy applications.
BiotechHealthtechMedical Devices
Merck is a science-led pharmaceutical company that develops medicines and vaccines for patients globally.
BiotechHealthtechMedical Devices
Rob Davisin
Co-investorsMESA VERDE VENTURE PARTNERS
Metavention is developing a treatment that targets the sympathetic nervous system to disrupt overactive nerves believed to contribute to high blood pressure and other metabolic diseases.
BiotechHealthtechMedical DevicesEden Prairie, US
Bobak Azamian(Executive Officer, Director)Tony Vrba(Executive Officer)Kevin Hykes(Executive Officer, Director)Kirk Nielsen(Director)in
Co-investorsNew Enterprise Associates (NEA)Vensana CapitalVersant Ventures
CMR Naviscan develops a breast imaging technology aimed at improving invasive cancer detection rates and reducing unnecessary biopsies, particularly in women with dense breast tissue.
HardwareHealthtechMedical DevicesCarlsbad, US
Co-investorsQuestMark Partners
Pacira develops and commercializes non-opioid therapies for postsurgical, chronic, and musculoskeletal pain, and is advancing a gene therapy pipeline candidate.
BiotechHealthtech
Regeneron is a biotechnology company that develops medicines ranging from biologics to genetic medicines to treat serious diseases across areas such as metabolic disease, ophthalmology, and rare disease.
BiotechHealthtechTarrytown, US
Co-investorsRidgeback CapitalvenBio PartnersWireframe Ventures
The site provides cardiovascular technology information for healthcare professionals and patients, covering cardiac and vascular products, therapies, and clinical evidence for treating conditions such as AFib and heart failure.
HardwareHealthtechMedical DevicesAbbott Park, US
Sotera Wireless manufactures the ViSi Mobile System, a wearable patient monitoring platform that continuously tracks vital signs including blood pressure, oxygen saturation, heart rate, and ECG in general hospital care settings.
AI & Machine LearningHealthtechMedical Devices
TheraVida is a clinical-stage specialty pharmaceutical company developing combination drug therapies for patients with hyperhidrosis (excessive sweating).
BiotechHealthtechMedical DevicesChapel Hill, US
Benjamin F. McGraw(CEO & Chairman)Rhonda Donahoe(CFO)Assad Kazeminy(VP, Business Development)Mehdi Paborji(Executive Officer, Director)Roger L. Flugel(Executive Officer, Director)Roger S. Flugel(Executive Officer, Director)
Transforming the lives of patients through a functional cure for Type 1 Diabetes
BiotechSan Diego, US
Brittany Bradrick(Executive Officer)Anne Sandan(Executive Officer)Elizabeth Bui(Executive Officer)Steve White(Executive Officer)Howard Foyt(Executive Officer)inKevin D'Amour(Executive Officer)in
Co-investorsArtis VenturesATEL VenturesBain Capital Life SciencesRA CapitalThe Vertical GroupJohnson & Johnson Innovation – JJDC+1 more
XOMA Royalty is a biotech royalty aggregator that acquires the economic rights to future milestone and royalty payments tied to partnered pre-commercial clinical candidates, providing sellers with non-dilutive, non-recourse funding.
BiotechFintech
Owen Hughes(Chief Executive Officer)inJeffrey Trigilio(Chief Financial Officer)inBrad Sitko(Chief Investment Officer)inMaricel Montano(Chief Legal Officer)
Co-investorsHEALTHCARE ROYALTY PARTNERSLigand Pharmaceuticals
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
CalciMedica SubsidiarySotera WirelessAlxnArtielleAxikin PharmaceuticalsCardioNetCephalon IncCrbardDalco PharmaISTA NASDAQ: ISTA www.istavision.comIsta VisionKadmusLiphorusLiphorus www.liphorus.comOntargetjobsPaciraPulsar VascularRegeneronSenhwabiosciencesTaligen TherapeuticsTorax MedicalUltraBridgeUniversity of Colorado's License Equity Holdings, Inc. (ULEHI)Ventritex
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 22
4 IPOs · 18 acquisitions · showing 18HCW BiologicsNASDAQ: HCWBBoston ScientificNYSE: BSXCalcimedicaNASDAQ: CALCStereotaxisNYSE: STXSSotera Wirelessacq. by Foxconn (Hon Hai Precision Industry)Actimisacq. by Boehringer IngelheimAderisacq. by Schwarz PharmaDepoTechacq. by SkyePharmaDynavaxacq. by SanofiEndocyteacq. by NovartisInfraReDxacq. by Nipro CorporationInterMuneacq. by RocheKadmusacq. by N.V. Organon (Akzo Nobel)Naviscanacq. by CMR NaviscanSjmacq. by AbbottTorax Medicalacq. by Ethicon (Johnson & Johnson)Ventritexacq. by St. Jude MedicalXOMAacq. by Ligand
Portfolio news
latest coverage across their companiesMerck · merck.com · Mar 19, 2026
Frequently asked questions
- How many investments has Sanderling Ventures made?
- Sanderling Ventures has 61 tracked investments, 22 of which have exited.
- What stage does Sanderling Ventures invest at?
- Sanderling Ventures invests at the Seed, Series A, Late Stage stages.
- What is Sanderling Ventures's typical check size?
- Sanderling Ventures typically writes checks of $50K – $1M.
- What sectors does Sanderling Ventures focus on?
- Sanderling Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Sanderling Ventures located?
- Sanderling Ventures is headquartered in San Mateo, US.
- Who does Sanderling Ventures co-invest with?
- Sanderling Ventures most often shares deals with Aisling Capital, New Enterprise Associates (NEA), Oak Investment Partners, among 59 tracked co-investors.
Images
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.
US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.
Black Opal Ventures is a venture capital firm founded in 2021 by Tara Bishop and Eileen Tanghal, investing at the intersection of technology and healthcare.